BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7425017)

  • 21. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubo-ovarian abscess occurring 16 years after supracervical hysterectomy.
    Tohya T; Yoshimura T; Onoda C
    Infect Dis Obstet Gynecol; 2003; 11(3):167-9. PubMed ID: 15022878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of ovarian actinomycosis.
    Iwasaki M; Nishikawa A; Akutagawa N; Fujimoto T; Teramoto M; Kudo R
    Infect Dis Obstet Gynecol; 2003; 11(3):171-3. PubMed ID: 15022879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IUD and salpingitis: a prospective study of pathomorphological changes in the oviducts in IUD-users.
    Beerthuizen RJ; Van Wijck JA; Eskes TK; Vermeulen AH; Vooijs GP
    Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):31-41. PubMed ID: 7060816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuboovarian abscess and the intrauterine device (Majzlin Spring).
    Duckman S; Suarez J; Tantakesem P
    Am J Obstet Gynecol; 1973 Apr; 115(8):1157-8. PubMed ID: 4691475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contraceptive practice in women with systemic lupus erythematosus.
    Julkunen HA; Kaaja R; Friman C
    Br J Rheumatol; 1993 Mar; 32(3):227-30. PubMed ID: 8448613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship of genital tract actinomycetes and the development of pelvic inflammatory disease.
    Burkman R; Schlesselman S; McCaffrey L; Gupta PK; Spence M
    Am J Obstet Gynecol; 1982 Jul; 143(5):585-9. PubMed ID: 7091230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuboovarian abscess caused by Candida in a woman with an intrauterine device.
    Hsu WC; Lee YH; Chang DY
    Gynecol Obstet Invest; 2007; 64(1):14-6. PubMed ID: 17192715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CUP: contraceptive users pamphlet.
    Adv Contracept Deliv Syst; 1986 Feb; 2(1):84-103. PubMed ID: 12267728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study.
    Kapustian V; Namazov A; Yaakov O; Volodarsky M; Anteby EY; Gemer O
    Arch Gynecol Obstet; 2018 May; 297(5):1201-1204. PubMed ID: 29478102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fertility awareness affects method use.
    Barnett B
    Netw Res Triangle Park N C; 1996; 17(1):9. PubMed ID: 12320448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abscessing salpingo-oophoritis caused by Actinomyces in a woman using an IUD].
    Milia S; D'Ovidio N; Firinu C
    Minerva Ginecol; 1983 Apr; 35(4):231-3. PubMed ID: 6888796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use-effectiveness of oral and intrauterine contraception.
    Tietze C; Lewitt S
    Fertil Steril; 1971 Aug; 22(8):508-13. PubMed ID: 5110233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trends in the diagnosis and treatment of tuboovarian abscess.
    Landers DV; Sweet RL
    Am J Obstet Gynecol; 1985 Apr; 151(8):1098-110. PubMed ID: 3885746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contraception and pelvic infection in women].
    Keith L; Berger GS; Brown ER
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):49-58. PubMed ID: 12341241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrauterine contraceptive device use and pelvic inflammatory disease.
    Kaufman DW; Shapiro S; Rosenberg L; Monson RR; Miettinen OS; Stolley PD; Slone D
    Am J Obstet Gynecol; 1980 Jan; 136(2):159-62. PubMed ID: 7352496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.